Protocol to analyze circulating small non-coding RNAs by high-throughput RNA sequencing from human plasma samples-Reference-Cited by-同舟云学术

Protocol to analyze circulating small non-coding RNAs by high-throughput RNA sequencing from human plasma samples

Published:2021-09 Issue:3 Volume:2 Page:100606
ISSN:2666-1667
Container-title:STAR Protocols
language:en
Short-container-title:STAR Protocols

Author:

Grieco Giuseppina E.^ORCID,Sebastiani Guido,Fignani Daniela^ORCID,Brusco Noemi^ORCID,Nigi Laura,Formichi Caterina^ORCID,Licata Giada^ORCID,Bruttini Marco^ORCID,D’Aurizio Romina^ORCID,Mathieu Chantal^ORCID,Gysemans Conny^ORCID,Dotta Francesco^ORCID

Publisher

Elsevier BV

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Reference23 articles.

1. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets;Andersen;Cancer Res.,2004

2. Assessing sample and miRNA profile quality in serum and plasma or other biofluids;Blondal;Methods,2013

3. Real-time quantification of microRNAs by stem-loop RT-PCR;Chen;Nucleic Acids Res.,2005

4. Plasma miRNA as biomarkers for assessment of total-body radiation exposure dosimetry;Cui;PLoS One,2011

5. Microparticles: major transport vehicles for distinct microRNAs in circulation;Diehl;Cardiovasc. Res.,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of individuals with recent-onset type 1 diabetes;Cell Reports Medicine;2024-06

2. A set of circulating microRNAs belonging to the 14q32 chromosomic locus identifies two clinically and phenotypically different subgroups of individuals with recent onset Stage 3 type 1 diabetes;2023-10-09

3. A Plasma miR-193b-365 Signature Combined With Age and Glycemic Status Predicts Response to Lactococcus lactis–Based Antigen-Specific Immunotherapy in New-Onset Type 1 Diabetes;Diabetes;2023-07-26

4. MicroRNA circolanti come biomarcatori per il diabete mellito di tipo 2: avanzamenti e prospettive future;L'Endocrinologo;2022-09-21

5. Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside;Translational Research;2022-09